Stonegate Capital has closed on a $3 million Senior Secured Credit Facility for the private equity-owned medical technology company, Monarch Medical Technologies.

The Company’s proprietary software improves hospital-based glucose management by replacing traditional paper and pencil linear protocols with individualized and predictive computer-based solutions. Monarch provides patient-specific insulin dosing, which significantly improves quality of care, reduces risk, and controls healthcare costs.

Stonegate worked closely with the private equity sponsor, Eigen Capital, to recognize the value in the Company’s technology solutions and to create a customized credit facility for the business. This investment aligns well with Stonegate’s support of the sponsor-backed software and technology space, and we look forward to our partnership with the Company as it continues to execute on its growth strategy.